Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.4451
-0.0029 (-0.65%)
At close: Nov 17, 2026, 4:00 PM EST
0.4540
+0.0089 (2.00%)
After-hours: Nov 17, 2026, 5:14 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $354.74 thousand as of November 17, 2026. It is the 50,661st most valuable company in the world and the 6,978th biggest in the United States. Its market cap has decreased by 82.29% in one year.
Market Cap
354.74K
Enterprise Value
-5.75M
1-Year Change
-82.29%
Global Rank
Country Rank
#6,978 United States
Category
ChartMarket Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $354.74K, a decrease of -99.83%. That is a compound annual growth rate of -77.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 488.24K | -80.98% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.38% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 937.01K |
| SciSparc | 834.37K |
| Oragenics | 830.65K |
| GeoVax Labs | 736.98K |
| Decoy Therapeutics | 598.45K |
| Lakewood-Amedex Biotherapeutics | 540.05K |
| Scinai Immunotherapeutics | 529.65K |
| Valion Bio | 451.69K |